These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18668139)

  • 1. Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells.
    Goldstein NB; Johannes WU; Gadeliya AV; Green MR; Fujita M; Norris DA; Shellman YG
    J Invest Dermatol; 2009 Feb; 129(2):432-7. PubMed ID: 18668139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic BRAF(V600E) inhibits BIM expression to promote melanoma cell survival.
    Cartlidge RA; Thomas GR; Cagnol S; Jong KA; Molton SA; Finch AJ; McMahon M
    Pigment Cell Melanoma Res; 2008 Oct; 21(5):534-44. PubMed ID: 18715233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic B-RAF(V600E) promotes anchorage-independent survival of human melanocytes.
    Becker TM; Philipsz S; Scurr LL; Fung C; Haferkamp S; Kefford RF; Rizos H
    J Invest Dermatol; 2010 Aug; 130(8):2144-7. PubMed ID: 20445557
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
    Boisvert-Adamo K; Aplin AE
    Oncogene; 2008 May; 27(23):3301-12. PubMed ID: 18246127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.
    Jiang CC; Lai F; Tay KH; Croft A; Rizos H; Becker TM; Yang F; Liu H; Thorne RF; Hersey P; Zhang XD
    Cell Death Dis; 2010 Sep; 1(9):e69. PubMed ID: 21364673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.
    Shao Y; Aplin AE
    Cancer Res; 2010 Aug; 70(16):6670-81. PubMed ID: 20647317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mcl-1 is required for melanoma cell resistance to anoikis.
    Boisvert-Adamo K; Longmate W; Abel EV; Aplin AE
    Mol Cancer Res; 2009 Apr; 7(4):549-56. PubMed ID: 19372583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Bim in the survival pathway induced by Raf in epithelial cells.
    Marani M; Hancock D; Lopes R; Tenev T; Downward J; Lemoine NR
    Oncogene; 2004 Apr; 23(14):2431-41. PubMed ID: 14676826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic B-RafV600E inhibits apoptosis and promotes ERK-dependent inactivation of Bad and Bim.
    Sheridan C; Brumatti G; Martin SJ
    J Biol Chem; 2008 Aug; 283(32):22128-35. PubMed ID: 18508762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.
    Wellbrock C; Marais R
    J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs.
    Yeh AH; Bohula EA; Macaulay VM
    Oncogene; 2006 Oct; 25(50):6574-81. PubMed ID: 16715137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression.
    Collins NL; Reginato MJ; Paulus JK; Sgroi DC; Labaer J; Brugge JS
    Mol Cell Biol; 2005 Jun; 25(12):5282-91. PubMed ID: 15923641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic.
    Cragg MS; Jansen ES; Cook M; Harris C; Strasser A; Scott CL
    J Clin Invest; 2008 Nov; 118(11):3651-9. PubMed ID: 18949058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway.
    Craxton A; Draves KE; Gruppi A; Clark EA
    J Exp Med; 2005 Nov; 202(10):1363-74. PubMed ID: 16301744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis.
    Reginato MJ; Mills KR; Paulus JK; Lynch DK; Sgroi DC; Debnath J; Muthuswamy SK; Brugge JS
    Nat Cell Biol; 2003 Aug; 5(8):733-40. PubMed ID: 12844146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
    Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
    J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines.
    Bloethner S; Chen B; Hemminki K; Müller-Berghaus J; Ugurel S; Schadendorf D; Kumar R
    Carcinogenesis; 2005 Jul; 26(7):1224-32. PubMed ID: 15760917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic B-Raf(V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells.
    Cui Y; Borysova MK; Johnson JO; Guadagno TM
    Cancer Res; 2010 Jan; 70(2):675-84. PubMed ID: 20068179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer therapy: boosting the bang of Bim.
    Hendrickson AW; Meng XW; Kaufmann SH
    J Clin Invest; 2008 Nov; 118(11):3582-4. PubMed ID: 18949061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.